Nanjing Vishee Medical Technology Valuation

Q: What is the Fair Price of 688580 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

688580 (CN¥28.81) is trading above our estimate of [[fair value]] (CN¥0.23)

Is 688580 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688580 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688580 (CN¥28.81) is trading above our estimate of fair value (CN¥0.23)

Significantly Below Fair Value: 688580 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688580?

Key metric: As 688580 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688580. This is calculated by dividing 688580's market cap by their current earnings.
What is 688580's PE Ratio?
PE Ratio	24.3x
Earnings	CN¥112.74m
Market Cap	CN¥2.74b

688580 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.1x
Enterprise Value/EBITDA	15.1x
PEG Ratio	0.8x

Price to Earnings Ratio vs Peers

How does 688580's PE Ratio compare to its peers?

The above table shows the PE ratio for 688580 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	29.4x
688358 Chison Medical Technologies	26.1x	34.9%	CN¥2.7b
301290 Jiangsu Canopus Wisdom Medical TechnologyLtd	29.3x	n/a	CN¥2.7b
688273 Nanjing Medlander Medical TechnologyLtd	23.9x	n/a	CN¥2.4b
300314 Ningbo David Medical Device	38.4x	42.0%	CN¥3.4b
688580 Nanjing Vishee Medical Technology	24.3x	29.3%	CN¥2.7b

Price-To-Earnings vs Peers: 688580 is good value based on its Price-To-Earnings Ratio (24.3x) compared to the peer average (29.4x).

Price to Earnings Ratio vs Industry

How does 688580's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688580 is good value based on its Price-To-Earnings Ratio (24.3x) compared to the CN Medical Equipment industry average (36.6x).

Price to Earnings Ratio vs Fair Ratio

What is 688580's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688580 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	24.3x
Fair PE Ratio	27.9x

Price-To-Earnings vs Fair Ratio: 688580 is good value based on its Price-To-Earnings Ratio (24.3x) compared to the estimated Fair Price-To-Earnings Ratio (27.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688580 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥28.81	CN¥36.97 +28.3%	10.7%	CN¥40.94	CN¥33.00	n/a	2
Nov ’25	CN¥28.15	CN¥36.97 +31.3%	10.7%	CN¥40.94	CN¥33.00	n/a	2
Oct ’25	CN¥29.48	CN¥36.97 +25.4%	10.7%	CN¥40.94	CN¥33.00	n/a	2
Sep ’25	CN¥23.31	CN¥36.97 +58.6%	10.7%	CN¥40.94	CN¥33.00	n/a	2
Aug ’25	CN¥25.29	CN¥42.61 +68.5%	3.9%	CN¥44.29	CN¥40.94	n/a	2
Jul ’25	CN¥26.85	CN¥42.61 +58.7%	3.9%	CN¥44.29	CN¥40.94	n/a	2
Jun ’25	CN¥32.28	CN¥42.61 +32.0%	3.9%	CN¥44.29	CN¥40.94	n/a	2
Jan ’25	CN¥45.66	CN¥55.41 +21.3%	0.7%	CN¥55.81	CN¥55.00	n/a	2
Dec ’24	CN¥48.88	CN¥55.41 +13.4%	0.7%	CN¥55.81	CN¥55.00	n/a	2
Nov ’24	CN¥43.53	CN¥55.41 +27.3%	0.7%	CN¥55.81	CN¥55.00	CN¥28.15	2
Oct ’24	CN¥48.86	CN¥55.41 +13.4%	0.7%	CN¥55.81	CN¥55.00	CN¥29.48	2
Sep ’24	CN¥46.34	CN¥55.41 +19.6%	0.7%	CN¥55.81	CN¥55.00	CN¥23.31	2
Aug ’24	CN¥44.92	CN¥59.69 +32.9%	6.5%	CN¥63.57	CN¥55.81	CN¥25.29	2
Jul ’24	CN¥51.64	CN¥59.69 +15.6%	6.5%	CN¥63.57	CN¥55.81	CN¥26.85	2
Dec ’23	CN¥40.45	CN¥53.74 +32.8%	9.6%	CN¥58.90	CN¥48.57	CN¥48.88	2
Nov ’23	CN¥41.14	CN¥53.74 +30.6%	9.6%	CN¥58.90	CN¥48.57	CN¥43.53	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.53

-5.8%

-34.9%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.72

-2.1%

28.8%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.90

5.4%

-14.7%